Vericel Corp.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $57.88
- 52-Week Range
- $28.95 – $59.75
- Market Cap
- $2.99B
- P/E (TTM)
- 91.64
- EPS (TTM)
- 0.64
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 7.79
- PEG Ratio
- —
- Return on Equity
- 9.44%
- Return on Assets
- 3.47%
- Gross Margin
- 74.47%
- Operating Margin
- 8.32%
- Profit Margin
- 10.27%
- Current Ratio
- 5.13
- Debt/Equity
- 0.24
- Total Debt
- $91.15M
- Free Cash Flow
- $49.89M
- Revenue Growth
- 26.50%
- Earnings Growth
- 170.00%
- Enterprise Value
- $2.91B
Market Snapshot
About
Vericel Corp. is a leader in advanced therapies for the sports medicine and severe burn care markets. The company commercializes autologous cell therapy products including MACI for cartilage repair and Epicel for severe burns.